Healthways (HWAY) Misses Q3 EPS by 22c

Healthways (NASDAQ: HWAY) reported Q3 EPS of $0.30, $0.22 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $125 million versus the consensus estimate of $124.71 million.

For earnings history and earnings-related data on Healthways (HWAY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c